Activation of the transforming growth factor β signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol

Cancer Research

Volumn 59, Issue 8, 1999, Pages 1917-1928

  Ariazi, Eric A ^a   Satomi, Yoshiko ^a   Ellis, Matthew J ^b   Haag, Jill D ^a   Shi, Wenge ^a   Sattler, Carol A ^a   Gould, Michael N ^a,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERILLYL ALCOHOL; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CYTOSTASIS; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; FEMALE; MAMMARY NEOPLASMS, ANIMAL; MONOTERPENES; RATS; RATS, WISTAR; RNA, NEOPLASM; SIGNAL TRANSDUCTION; TERPENES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033561642     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Crowell, P. L., and Gould, M. N. Chemoprevention and therapy of cancer by d-limonene. Crit. Rev. Oncog., 5: 1-22, 1994.
2. Crowell, P. L., Siar Ayoubi, A., and Burke, Y. D. Antitumorigenic effects of limonene and perillyl alcohol against pancreatic and breast cancer. Adv. Exp. Med. Biol., 401: 131-136, 1996.
3. Gould, M. N., Wacker, W. D., and Maltzman, T. H. Chemoprevention and chemotherapy of mammary tumors by monoterpenoids. Prog. Clin. Biol. Res., 347: 255-268, 1990.
4. Gould, M. N. Prevention and therapy of mammary cancer by monoterpenes. J. Cell. Biochem. Suppl., 22: 139-144, 1995.
5. Gould, M. N. Cancer Chemoprevention and therapy by monoterpenes. Environ. Health Perspect., 105: 917-979, 1997.
6. Haag, J. D., Lindstrom, M. J., and Gould, M. N. Limonene-induced regression of mammary carcinomas. Cancer Res., 52: 4021-4026, 1992.
7. Haag, J. D., and Gould, M. N. Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene. Cancer Chemother. Pharmacol., 34: 477-483, 1994.
8. Vigushin, D. M., Poon, G. K., Boddy, A., English, J., Halbert, G. W., Pagonis, C., Jarman, M., and Coombes, R. C. Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee. Cancer Chemother. Pharmacol., 42: 111-117, 1998.
9. Ripple, G. H., Gould, M. N., Stewart, J. A., Tutsch, K. D., Arzoomanian, R. Z., Alberti, D., Feierabend, C., Pomplun, M., Wilding, G., and Bailey, H. H. Phase I clinical trial of perillyl alcohol administered daily. Clin. Cancer Res., 4: 1159-1164, 1998.
10. Hohl, R., Ripple, G., Gould, M., Marnocha. R., Arzoomanian, R., Alberti, D., Tutsch, K., Feierabend, C., Simon, K., Morgan, K., Stewart, J., Wahamaki, A., Pomplun, M., Lewis, K., Wilding. G., and Bailey, H. Phase I trial of perillyl alcohol given on a two weeks on, two weeks off schedule. Proc. Am. Assoc. Cancer Res., 39: 323, 1998.
11. Ariazi, E. A., and Gould, M. N. Identifying differential gene expression in monoterpene-treated mammary carcinomas using subtractive display. J. Biol. Chem., 271: 29286-29294, 1996.
12. Mills, J. J., Chari, R. S., Boyer, I. J., Gould, M. N., and Jirtle, R. L. Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res., 55: 979-983, 1995.
13. Jirtle, R. L., Haag, J. D., Ariazi, E. A., and Gould, M. N. Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor β 1 levels during monoterpene-induced regression of mammary tumors. Cancer Res., 53: 3849-3852, 1993.
14. Hankins, G. R., De Souza, A. T., Bentley, R. C., Patel, M. R., Marks, J. R., Iglehart, J. D., and Jirtle, R. L. M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene, 12: 2003-2009, 1996.
15. De Souza, A. T., Hankins, G. R., Washington, M. K., Orton, T. C., and Jirtle, R. L. M6P/IGF2K gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat. Genet., 11: 447-449, 1995.
16. Dennis, P. A., and Rifkin, D. B. Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc. Natl. Acad. Sci. USA, 88: 580-584, 1991.
17. Heldin, C. H., Miyazono, K., and ten Dijke, P. TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature (Lond.), 390: 465-471, 1997.
18. Kretzschmar, M., and Massague, J. SMADs: mediators and regulators of TGF-β signaling. Curr. Opin. Genet. Dev., 8: 103-111, 1998.
19. Hartsough, M. T., and Mulder, K. M. Transforming growth factor-β signaling in epithelial cells. Pharmacol. Ther., 75: 21-41, 1997.
20. Atfi, A., Djelloul, S., Chastre, E., Davis, R., and Gespach, C. Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor β-mediated signaling. J. Biol. Chem., 272: 1429-1432, 1997.
21. Daniel, C. W., and Robinson, S. D. Regulation of mammary growth and function by TGF-β. Mol. Reprod. Dev., 32: 145-151, 1992.
22. 1 phase and cell cycle regulation by TGF-β. Adv. Cancer Res., 71: 165-207, 1997.
23. Moustakas, A., and Kardassis, D. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between SpI and smad family members. Proc. Natl. Acad. Sci. USA, 95: 6733-6738, 1998.
24. 1 arrest caused by the anticancer monoterpene, perillyl alcohol (POH) in mammary cells. Proc. Am. Assoc. Cancer Res., 39: 20, 1998.
25. Yu, W., Heim, K., Qian, M., Simmons-Menchaca, M., Sanders, B. G., and Kline, K. Evidence for role of transforming growth factor-β in RRR-a-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells. Nutr. Cancer, 27: 267-278, 1997.
26. Strange, R., Li, F., Saurer, S., Burkhardt, A., and Friis, R. R. Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development, 115: 49-58, 1992.
27. McKanna, J. A. Lipocortin 1 in apoptosis: mammary regression. Anal. Rec., 242: 1-10, 1995.
28. Stark, M. J., Burke, Y. D., McKinzie, J. H., Ayoubi, A. S., and Crowell, P. L. Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol. Cancer Lett., 96: 15-21, 1995.
29. Stayrook, K. R., McKinzie, J. H., Burke, Y. D., Burke, Y. A., and Crowell, P. L. Induction of the apoptosis-promoting protein Bak by perillyl alcohol in pancreatic ductal adenocarcinoma relative to untransformed ductal epithelial cells. Carcinogenesis (Lond.), 18: 1655-1658, 1997.
30. Reddy, B. S., Wang, C. X., Samaha, H., Lubet, R., Steele, V. E., Kelloff, G. J., and Rao, C. V. Chemoprevention of colon carcinogenesis by dietary perillyl alcohol. Cancer Res., 57: 420-425, 1997.
31. Phillips, L. R., Malspeis, L., and Supko, J. G. Pharmacokinetics of active drug metabolites after oral administration of perillyl alcohol, an investigational antineoplastic agent, to the dog. Drug Metab. Dispos., 23: 676-680, 1995.
32. Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D. J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res., 25: 3389-3402, 1997.
33. Russo, J., Saby, J., Isenberg, W. M., and Russo, I. H. Pathogenesis of mammary carcinomas induced in rats by 7,12-dimethylbenz[a]anthracene. J. Natl. Cancer Inst., 59: 435-445, 1977.
34. Walker, N. I., Bennett, R. E., and Kerr, J. F. R. Cell death by apoptosis during involution of the lactating breast in mice and rats. Am. J. Anat., 185: 19-32, 1989.
35. Huovinen, R., Warri, A., and Collan, Y. Mitotic activity, apoptosis and TRPM-2 mRNA expression in DMBA-induced rat mammary carcinoma treated with anti-estrogen toremifene. Int. J. Cancer, 55: 685-691, 1993.
36. Datto, M. B., Li, Y., Panus, J. F., Howe, D. J., Xiong, Y., and Wang, X. F. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA. 92: 5545-5549, 1995.
37. Duttaroy, A., Qian, J. F., Smith, J. S., and Wang, E. Up-regulated P21CIP1 expression is part of the regulation quantitatively controlling serum deprivation-induced apoptosis. J. Cell. Biochem., 64: 434-446, 1997.
38. Li, M., Hu, J., Heermeier, K., Hennighausen, L., and Furth, P. A. Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways. Cell Growth Differ., 7: 13-20, 1996.
39. Allen, R. T., Cluck, M. W., and Agrawal, D. K. Mechanisms controlling cellular suicide: role of Bcl-2 and caspases. Cell. Mol. Life Sci., 54: 427-445, 1998.
40. Kroemer, G. The proto-oneogene Bcl-2 and its role in regulating apoptosis [published erratum appears in Nat. Med., 3: 934, 1997]. Nat. Med., 3: 614-620, 1997.
41. Frey, R. S., and Mulder, K. M. Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor β in the negative growth control of breast cancer cells. Cancer Res., 57: 628-633, 1997.
42. Minden, A., Lin, A., Smeal, T., Derijard, B., Cobb, M., Davis, R., and Karin, M. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-aclivated protein kinases. Mol. Cell. Biol., 14: 6683-6688, 1994.
43. Angel, P., Hattori, K., Smeal, T., and Karin, M. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell, 55: 875-885, 1988.
44. Kim, S. J., Angel, P., Lafyatis, R., Hattori, K., Kim, K. Y., Sporn, M. B., Karin, M., and Roberts, A. B. Autoinduction of transforming growth factor β 1 is mediated by the AP-1 complex. Mol. Cell. Biol., 10: 1492-1497, 1990.
45. Kleeff, J., and Korc, M. Up-regulation of transforming growth factor (TGF)-β receptors by TGF-β1 in COLO-357 cells. J. Biol. Chem., 275: 7495-7500, 1998.
46. Zawel, L., Le Dai, J., Buckhaults, P., Zhou, S., Kinzler, K. W., Vogelstein, B., and Kern, S. E. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell., 1: 611-617, 1998.
47. Vindevoghel, L., Kon, A., Lechleider, R. J., Uitto, J., Roberts, A. B., and Mauviel, A. Smad-dependent transcriptional activation of human type VII collagen gene (COL7A1) promoter by transforming growth factor-β. J. Biol. Chem., 273: 13053-13057, 1998.
48. Dennler, S., Itoh, S., Vivien, D., ten Dijke, P., Huet, S., and Gauthier, J-M. Direct binding of smad3 and smad4 to critical TGF-β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J., 17: 3091-3100, 1998.
49. Yingling, J. M., Datto, M. B., Wong, C., Frederick, J. P., Liberati, N. T., and Wang, X. F. Tumor suppressor 4mad4 is a transforming growth factor β-inducible DNA binding protein. Mol. Cell. Biol., 17: 7019-7028, 1997.
50. Bloom, B. B., Humphries, D. E., Kuang, P. P., Fine, A., and Goldstein, R. H. Structure and expression of the promoter for the R4/ALK5 human type 1 transforming growth factor-β receptor: regulation by TGF-β. Biochim. Biophys. Acta., 1312: 243-248, 1996.
51. Humphries, D. E., Bloom, B. B., Fine, A., and Goldstein, R. H. Structure and expression of the promoter for the human type II transforming growth factor-β receptor, Biochem. Biophys. Res. Commun., 203: 1020-1027, 1994.
52. Nakao, A., Imamura, T., Souchelnytskyi, S., Kawabata, M., Ishisaki, A., Oeda, E., Tamaki, K., Hanai, J., Heldin, C. H., Miyazono, K., and ten Dijke, P. TGF-β receptor-mediated signaling through Smad2, Smad3 and Smad4. EMBO J., 16: 5353-5362, 1997.
53. Liu, X., Sun, Y., Constantinescu, S. N., Karam, E., Weinberg, R. A., and Lodish, H. F. Transforming growth factor ß-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc. Natl. Acad. Sci. USA, 94: 10669-10674, 1997.
54. Atfi, A., Buisine, M., Mazars, A., and Gespach, C. Induction of apoptosis by DPC4, a transcriptional factor regulated by transforming growth factor-β through stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signaling pathway. J. Biol. Chem., 272: 24731-24734, 1997.
55. Liu, F., Pouponnot, C., and Massague, J. Dual role of the Smad4/DPC4 tumor suppressor in TGF-β-inducible transcriptional complexes. Genes Dev., 11: 3157-3167, 1997.